The TREAT-NMD advisory committee for therapeutics (TACT): an innovative de-risking model to foster orphan drug development. (2015)

First Author: Heslop E
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13023-015-0258-1

PubMed Identifier: 25902795

Publication URI: http://europepmc.org/abstract/MED/25902795

Type: Journal Article/Review

Volume: 10

Parent Publication: Orphanet journal of rare diseases

ISSN: 1750-1172